TipRanks
Advertisement
Advertisement

ANAB Stock Latest News

ANAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsANAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6d ago
ANAB
AnaptysBio price target lowered to $70 from $75 at TD Cowen
PremiumThe Fly
AnaptysBio price target lowered to $70 from $75 at TD Cowen
21d ago
GSK
ANAB
Jemperli Priority Review and Litigation Update Reinforce AnaptysBio Buy Rating with Unchanged $95 Price Target
PremiumRatings
Jemperli Priority Review and Litigation Update Reinforce AnaptysBio Buy Rating with Unchanged $95 Price Target
22d ago
ANAB
AnaptysBio options imply 5.0% move in share price post-earnings
PremiumThe Fly
AnaptysBio options imply 5.0% move in share price post-earnings
29d ago
ANAB
AnaptysBio options imply 7.0% move in share price post-earnings
PremiumThe Fly
AnaptysBio options imply 7.0% move in share price post-earnings
1M ago
ANAB
AnaptysBio Shareholders Back Board, Governance and Incentives
PremiumCompany AnnouncementsAnaptysBio Shareholders Back Board, Governance and Incentives
1M ago
8K
ANAB
Is ANAB a Buy, Before Earnings?
Premium
Pre-Earnings
Is ANAB a Buy, Before Earnings?
1M ago
ANAB
AnaptysBio Enters Key Post-Trial Phase in Tesaro Dispute
Premium
Company Announcements
AnaptysBio Enters Key Post-Trial Phase in Tesaro Dispute
2M ago
8K
ANAB
Buy Rating Reaffirmed on Litigation Clarity and Asset Value; $95 Price Target Maintained
PremiumRatings
Buy Rating Reaffirmed on Litigation Clarity and Asset Value; $95 Price Target Maintained
2M ago
ANAB
AnaptysBio falls -10.8%
PremiumThe Fly
AnaptysBio falls -10.8%
2M ago
ANAB
AnaptysBio: Buy Rating Reiterated as Jemperli Data De-Risks Program; $95 Price Target Maintained
PremiumRatings
AnaptysBio: Buy Rating Reiterated as Jemperli Data De-Risks Program; $95 Price Target Maintained
2M ago
ANAB
AnaptysBio Subleases San Diego Facility to First Tracks
PremiumCompany Announcements
AnaptysBio Subleases San Diego Facility to First Tracks
3M ago
8K
ANAB
AnaptysBio assumed with a Buy at H.C. Wainwright
PremiumThe FlyAnaptysBio assumed with a Buy at H.C. Wainwright
3M ago
ANAB
AnaptysBio Details Tax Treatment of Spin-Off Dividend
Premium
Company Announcements
AnaptysBio Details Tax Treatment of Spin-Off Dividend
4M ago
8K
ANAB
AnaptysBio Adjusts Fiscal Year-End and Reporting Calendar
Premium
Company Announcements
AnaptysBio Adjusts Fiscal Year-End and Reporting Calendar
4M ago
8K
ANAB
AnaptysBio price target raised to $90 from $85 at Leerink
PremiumThe Fly
AnaptysBio price target raised to $90 from $85 at Leerink
4M ago
GSK
ANAB
AnaptysBio Split Raises Execution, Cost and Governance Risks as Royalty Dependence and Valuation Uncertainty Grow
PremiumCompany Announcements
AnaptysBio Split Raises Execution, Cost and Governance Risks as Royalty Dependence and Valuation Uncertainty Grow
4M ago
ANAB
AnaptysBio price target raised to $76 from $60 at UBS
PremiumThe Fly
AnaptysBio price target raised to $76 from $60 at UBS
4M ago
ANAB
AnaptysBio price target raised to $75 from $63 at Barclays
PremiumThe Fly
AnaptysBio price target raised to $75 from $63 at Barclays
4M ago
ANAB
AnaptysBio reports Q1 EPS ($1.84), consensus (75c)
PremiumThe FlyAnaptysBio reports Q1 EPS ($1.84), consensus (75c)
4M ago
ANAB
AnaptysBio Appoints New CFO and Board Director
Premium
Company Announcements
AnaptysBio Appoints New CFO and Board Director
4M ago
8K
ANAB
AnaptysBio appoints Christopher Murphy as CFO
Premium
The Fly
AnaptysBio appoints Christopher Murphy as CFO
4M ago
ANAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >